Jump to Main Contents
国立がん研究センター 中央病院

Home > ATLAS Project Research Members

ATLAS Project Research Members

National Cancer Center Hospital (Tokyo, Japan)

TERADA Mitsumi (Asian Partnerships Offece, Department of International Clinical Development)


TERADA Mitsumi MD, PhD

Dr. TERADA's story

Dr. Terada graduated with his MD from the Jikei University in 2009 and obtained PhD in 2019.
From 2011 to 2016, he worked as a surgeon for gastrointestinal cancer, especially for gastric cancer from 2014. He joined the EORTC in 2017 as a medical research fellow and learned methodology of international clinical trials on European basis. At the EORTC, he proposed and organized some collaborative projects and events between JCOG (Japan Clinical Oncology Group) and EORTC, which let him realize how important and significant the international collaboration is. He is also interested in PRO/QOL research for cancer patients and a chief investigator of an international collaborative study to update the EORTC QLQ STO22 that is QOL questionnaire for gastric cancer.
In 2019, he was mainly involved in the establishment of Asian Partnerships Office (APO) in Bangkok, Thailand under the ATLAS project and appointed General Manager of APO in September 2021. He resides in Bangkok from December 2021, and will contribute to development of the partnerships with multiple stakeholders and establishment of governance structure for the ATLAS network.

Research interests

Clinical trial methodology, PRO/QOL research for cancer patinets

Professional Experiences

  • Sep 2021-present: General Manager, Asian Partnerships Office, Department of International Clinical Development, NCCH, Japan
  • Jun 2019-present: Medical staff, International Trials Management Section, NCCH, Japan
  • Jun 2017-May 2019: Medical Research Fellow (Medical Department), EORTC HQ, and Clinical Research Fellow (International Trials Management Section), JCOG/NCCH Japan
  • Oct 2016-May 2017: Clinical Research Resident, Japan Clinical Oncology Group (JCOG)
  • Apr 2014-Sep 2016: Resident (Gastric surgery) National Cancer Center Hospital East, Chiba, Japan

Selected publications

  1. Honda, M.; Hiki, N.; Kinoshita, T.; Yabusaki, H.; Abe, T.; Nunobe, S.; Terada, M.; Matsuki, A.; Sunagawa, H.; Aizawa, M.; Healy, M. A.; Iwasaki, M.; Furukawa, T. A., Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage I Gastric Cancer: The LOC-1 Study. Ann. Surg. 2016, 264 (2), 214-22.
  2. Terada M, Kinoshita T, Kaito A, Sugita S, Watanabe M, Hayashi R. Evaluation of the prognostic factors in patients with pT3N0 or pT1N2-3 gastric cancer: a single institutional retrospective cohort study. Surg Today. 2017, Oct 9. doi: 10.1007/s00595-017-1592-9.
  3. Kataoka K, Kaider-Person O, Kasper B, Starlinger P, Caballero C, Menis J, Hendriks LE, Terada M, Collette L, Nakamura K, Lacombe D, Fukuda H. Responding to the challenges of international collaborations between the east and the west - report of the first JCOG-EORTC symposium and a perspective from young JCOG and EORTC investigators. Jpn J Clin Oncol. 2019 Jan 1;49(1):96-99. doi: 10.1093/jjco/hyy155.
  4. Shunsaku Homma, Kentaro Yasuchika, Mitsumi Terada, Tadashi Ito. A case of a difficult preoperative diagnosis for a middle-aged male with solid-pseudopapillary neoplasm. Suizo. 2013 Jan; 28(5): 636-642. doi: 10.2958/suizo.28.636
  5. Vinches M, Neven A, Fenwarth L, Terada M, Rossi G, Kelly S, Peron J, Thomaso M, Grønvold M, De Rojas T. Clinical research in cancer palliative care: a metaresearch analysis. BMJ Support Palliat Care. 2020 Jun;10(2):249-258. doi: 10.1136/bmjspcare-2019-002086. Epub 2020 Mar 24.
  6. de Rojas T, Neven A, Terada M, García-Abós M, Moreno L, Gaspar N, Péron J. Access to Clinical Trials for Adolescents and Young Adults With Cancer: A Meta-Research Analysis. JNCI Cancer Spectr. 2019 Aug 1;3(4):pkz057. doi: 10.1093/jncics/pkz057. eCollection 2019 Dec
  7. Wagner AD, Lordick F, Grabsch HI, Terashima M, Terada M, Yoshikawa T, Boku N, Kataoka K, Smyth EC, Mauer M, Haustermans K, Moehler MH. Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer. Eur J Cancer. 2020 Jan;124:67-76. doi: 10.1016/j.ejca.2019.09.006. Epub 2019 Nov 20.
  8. Terada M, Hara H, Daiko H, Mizusawa J, Kadota T, Hori K, Ogawa H, Ogata T, Sakanaka K, Sakamoto T, Kato K, Kitagawa Y. Phase III study of tri-modality combination therapy with induction docetaxel plus cisplatin and 5-fluorouracil versus definitive chemoradiotherapy for locally advanced unresectable squamous-cell carcinoma of the thoracic esophagus (JCOG1510: TRIANgLE). Jpn J Clin Oncol. 2019 Dec 18;49(11):1055-1060. doi: 10.1093/jjco/hyz112
  9. Jammbe Z Musoro, Sodergren C Samantha, Corneel Coens, Alessia Pochesci, Mitsumi Terada, Madeleine T King, Mirjam AG Sprangers, Mogens Groenvold, Kim Cocks, Galina Velikova, Hans-Henning Flechtner Andrew Bottomley on behalf of the EORTC Quality of Life and Gastro-intestinal Groups. Minimally important differences for interpreting the EORTC QLQ-C30 in advanced colorectal cancer patients treated with chemotherapy. Colorectal Disease. accepted.
  10. Mitsumi Terada, Kenichi Nakamura, Francesca Martinelli, Madeline Pe, Junki Mizusawa, Junko Eba, Haruhiko Fukuda, Naomi Kiyota, Laureline Gatellier, Yoshiyuki Majima, Galina Velikova, and Andrew Bottomley. Results from a 1-day workshop on the
    assessment of quality of life in cancer patients: a joint initiative of the Japan Clinical Oncology
    Group and the European Organisation for Research and Treatment of Cancer. Jpn J Clin Oncol. in press.


  • European Organisation for Research and Treatment of Cancer: https://www.eortc.org/
  • EORTC Quality of Life Group: https://qol.eortc.org/
  • JCOG PRO/QoL research Committee (in Japanese): http://www.jcog.jp/basic/org/committee/proqol.html